Neurocrine Biosciences Inc (NBIX)
125.65
+0.65
(+0.52%)
USD |
NASDAQ |
Nov 22, 16:00
127.38
+1.73
(+1.38%)
After-Hours: 20:00
Neurocrine Biosciences Shares Outstanding: 101.25M for Oct. 24, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 24, 2024 | 101.25M |
September 30, 2024 | 101.20M |
July 26, 2024 | 100.98M |
June 30, 2024 | 100.90M |
April 25, 2024 | 100.64M |
March 31, 2024 | 100.58M |
March 25, 2024 | 100.58M |
February 05, 2024 | 99.51M |
December 31, 2023 | 98.70M |
October 25, 2023 | 98.25M |
September 30, 2023 | 98.20M |
July 26, 2023 | 97.65M |
June 30, 2023 | 97.60M |
April 26, 2023 | 97.57M |
March 31, 2023 | 97.50M |
March 20, 2023 | 97.53M |
March 15, 2023 | 97.53M |
January 31, 2023 | 96.59M |
December 31, 2022 | 96.50M |
October 28, 2022 | 96.13M |
September 30, 2022 | 96.10M |
July 28, 2022 | 95.64M |
June 30, 2022 | 95.60M |
April 28, 2022 | 95.58M |
March 31, 2022 | 95.50M |
Date | Value |
---|---|
March 21, 2022 | 95.51M |
March 15, 2022 | 95.51M |
February 07, 2022 | 95.24M |
December 31, 2021 | 94.90M |
October 27, 2021 | 94.87M |
September 30, 2021 | 94.80M |
July 28, 2021 | 94.65M |
June 30, 2021 | 94.60M |
April 29, 2021 | 94.55M |
March 31, 2021 | 94.50M |
March 23, 2021 | 94.54M |
March 15, 2021 | 94.53M |
January 29, 2021 | 93.94M |
December 31, 2020 | 93.50M |
November 04, 2020 | 93.43M |
September 30, 2020 | 93.40M |
July 28, 2020 | 93.25M |
June 30, 2020 | 93.20M |
April 30, 2020 | 92.87M |
March 31, 2020 | 92.80M |
March 23, 2020 | 92.78M |
March 15, 2020 | 92.78M |
January 31, 2020 | 92.29M |
December 31, 2019 | 92.27M |
October 29, 2019 | 92.09M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
92.27M
Minimum
Dec 31 2019
101.25M
Maximum
Oct 24 2024
96.09M
Average
95.51M
Median
Mar 15 2022
Shares Outstanding Benchmarks
Repligen Corp | 56.03M |
West Pharmaceutical Services Inc | 72.42M |
Bruker Corp | 151.60M |
The Cooper Companies Inc | 199.16M |
Integra Lifesciences Holdings Corp | 77.16M |